| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(87)80517-6 |
| P698 | PubMed publication ID | 3819949 |
| P2093 | author name string | Andrew M | |
| Kelton JG | |||
| Carter C | |||
| Saigal S | |||
| Castle V | |||
| P2860 | cites work | Frequency and mechanism of neonatal thrombocytopenia | Q33455586 |
| The bleeding time as a screening test for evaluation of platelet function | Q33464411 | ||
| Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant | Q33484161 | ||
| Timing and evolution of periventricular haemorrhage in infants weighing 1250 g or less at birth | Q38945157 | ||
| Intraventricular haemorrhage and haemostasis defects | Q38946089 | ||
| Coagulation Studies in Severe Birth Asphyxia | Q39496344 | ||
| Neonatal intraventricular hemorrhage | Q40301097 | ||
| Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm | Q40671726 | ||
| Outcome in infants 501 to 1000 gm birth weight delivered to residents of the McMaster Health Region | Q47233083 | ||
| Coagulation Defects in Hypoxic Full-term Newborn Infants | Q70620225 | ||
| Neonatal germinal matrix hemorrhage: Evidence of a progressive lesion | Q70878679 | ||
| Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic | Q71255350 | ||
| Clinical assessment of gestational age in the newborn infant | Q71466810 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | 457-464 | |
| P577 | publication date | 1987-03-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Clinical impact of neonatal thrombocytopenia | |
| P478 | volume | 110 |
| Q33373781 | A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns |
| Q33493763 | A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants |
| Q33382246 | Advances and controversies in neonatal ICU platelet transfusion practice |
| Q33382669 | An approach to the management of infants with impaired haemostasis |
| Q30469247 | Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens |
| Q33489648 | Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia |
| Q33379900 | Association of Neonatal Thrombocytopenia and Maternal Anti-HLA Antibodies |
| Q33496834 | Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates |
| Q48425826 | Clinical events in association with timing of intraventricular hemorrhage in preterm infants |
| Q33442148 | Developmental differences between newborn and adult mice in response to romiplostim |
| Q33409352 | Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice |
| Q33379984 | Effects of sepsis on neonatal thrombopoiesis |
| Q33437814 | Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development |
| Q71791726 | Fetal and neonatal thrombocytopenia |
| Q33392634 | Fetal and neonatal thrombocytopenia |
| Q33378272 | How I transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity |
| Q33348204 | Inter-NICU variation in rates and management of thrombocytopenia among very low birth-weight infants |
| Q28200791 | Interleukin-11 levels in healthy and thrombocytopenic neonates |
| Q33450351 | Intracranial hemorrhage in term or near-term newborns with persistent pulmonary hypertension |
| Q38657901 | Intraventricular hemorrhage and brain injury in the premature infant. Neuropathology and pathogenesis. |
| Q37611514 | Intraventricular hemorrhage in premature infants: mechanism of disease |
| Q33395092 | Is a small platelet mass associated with intraventricular hemorrhage in very low-birth-weight infants? |
| Q33375326 | Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates |
| Q35069158 | Megakaryocytopoiesis in the human fetus |
| Q33433849 | Neonatal Immune Thrombocytopenia |
| Q26827381 | Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network |
| Q38390294 | Neonatal haemostasis |
| Q33403380 | Neonatal thrombocytopenia and platelets transfusion |
| Q24673677 | Neonatal thrombocytopenia: causes and management |
| Q33414184 | Neonatal thrombocytopenia: etiology, management and outcome |
| Q33502066 | Neonatal thrombocytopenia: incidence and characterization of maternal antiplatelet antibodies by MAIPA assay |
| Q35556499 | Neonatal transfusion practice |
| Q35535157 | One size will never fit all: the future of research in pediatric transfusion medicine |
| Q63916614 | Ontogeny of platelet function |
| Q34032611 | Performing and interpreting the bleeding time in the neonatal intensive care unit |
| Q33333554 | Perinatal thrombocytopenia of maternal origin |
| Q33331487 | Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys |
| Q33432436 | Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants. |
| Q27013796 | Platelet Transfusions in the Neonatal Intensive Care Unit |
| Q33403314 | Platelet count and serum thrombopoietin level as predictors for morbidity and/or mortality in thrombocytopenic neonates |
| Q33499533 | Platelet disorders in newborn infants: diagnosis and management |
| Q33488344 | Platelet transfusion therapy in newborn infants |
| Q33395699 | Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland |
| Q33489531 | Platelet transfusions in neonatology |
| Q47622222 | Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions |
| Q93342943 | Platelet-Neutrophil Interactions Are Lower in Cord Blood of Premature Newborns |
| Q38176626 | Preventing germinal matrix layer rupture and intraventricular hemorrhage |
| Q33425531 | Prognostic significance of early platelet count decline in preterm newborns |
| Q37209117 | Recommendations for the transfusion of plasma and platelets |
| Q33403712 | Restrictive guideline reduces platelet count thresholds for transfusions in very low birth weight preterm infants |
| Q35728878 | Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates |
| Q47377744 | Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: soy oil and marine oil supplementation of formula |
| Q33403539 | The prevalence and outcomes of thrombocytopenia in a neonatal intensive care unit: a three-year report |
| Q33394096 | Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study |
| Q71124262 | Thrombocytopenia in the neonate |
| Q33374735 | Thrombocytopenia related neonatal outcome in preterms |
| Q33331485 | Thrombopoietin and neonatal thrombocytopenia |
| Q33333802 | Thrombopoietin in the fetus and neonate |
| Q40998004 | What's new in transfusion medicine? |
Search more.